SCHEMBL6880948

SCHEMBL6880948

CC(=O)Nc1nc(Cl)c2[nH]c([C@@H]3O[C@H](CO)C[C@H]3O)nc2n1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.33
ACHE P22303 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6888251 0.76 ACHE (0.36) BCHEACHE
SCHEMBL6886972 0.75 EGLN1 (0.35)
SCHEMBL6884766 0.71 TSHR (0.44) BCHEACHE
SCHEMBL6887365 0.67 TP53 (0.35)
SCHEMBL6886459 0.64 ALDH1A1 (0.34)
SCHEMBL5197101 0.61 GDA (0.54)
SCHEMBL6886970 0.58 SLC5A2 (0.32)
SCHEMBL11561386 0.58 L3MBTL1 (0.51)
SCHEMBL16513139 0.58 POLB (0.42)
SCHEMBL16513144 0.57 POLB (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411954-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION Pharmasset Limited (BB) 2004-04-28 EP disclosed
WO-2002032920-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION PHARMASSET LIMITED (BB) 2002-04-25 WO disclosed